PlanHub, the leading preconstruction platform connecting general contractors, subcontractors, and suppliers nationwide, today announced a new national Capstone and Member Discount partnership with the ...

Collaboration will leverage AGC Biologics’ commercial manufacturing experience and proven platforms to seek regulatory approval for a therapy treating the rare immunodeficiency disorder, ADA-SCID.

Expands Offerings, Scale and Geographic Reach to Service Global Enterprise Clients Offer Price Represents a 24% Premium Over Most Recent Closing Price on Friday, November 9, 2018 DALLAS and MUMBAI, ...

AGC Biologics Partners with Quell Therapeutics to Advance T-Regulatory Cell Therapies for Immune Disorders AGC Biologics, your friendly CDMO expert, today announced a partnership with Quell ...

SEATTLE, May 5, 2020 /PRNewswire/ -- AGC Biologics, a global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has been selected to commercially manufacture the treatment ...

Global CDMO supports South Korean company on a multiphase project at its Copenhagen and Chiba sites Novelty Nobility develops innovative antibody drugs, including bispecific antibodies and ...

BOSTON--(BUSINESS WIRE)--Iron Mountain Incorporated (NYSE: IRM), the storage and information management services company, today announced the formation of a 300 million+ Euro joint venture (the ...

AGC Biologics Partners with Rarity PBC to Advance Life-Saving Gene Therapy for "Bubble Baby Disease" Collaboration will leverage AGC Biologics’ commercial manufacturing experience and proven platforms ...

SEATTLE & MILAN--(BUSINESS WIRE)-- AGC Biologics, your friendly CDMO expert, today announced a partnership with Quell Therapeutics (“Quell”), a clinical-stage biotechnology company pioneering ...